Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

ALT Flares in Patients with Chronic HBV Infection

Clin Gastroenterol Hepatol; ePub 2019 Feb 8; Brahmania, et al

The cumulative incidence of severe alanine aminotransferase (ALT) flares was low and associated with greater decreases in HBV DNA and loss of HBeAg, but not with loss of HBsAg, in a racially heterogeneous cohort of adults with chronic hepatitis B virus (HBV) infection. Researchers collected clinical and laboratory data from 1,587 participants in the Hepatitis B Research Network at enrollment, at weeks 12 and 24, and every 24 weeks thereafter for a planned 5 years of follow-up from January 2011 through May 2016. They found:

  • ALT flares occurred in 102 (6%) participants, with 31 (30%) flares occurring at baseline.
  • The 4-year cumulative incidence of ALT flares was 5.7%.
  • Male sex and higher baseline HBV DNA values were associated with occurrence of an ALT flare; older age was associated with lower odds of an ALT flare.
  • Rate of decrease in level on HBV DNA by ≥ 1 log10 and HBeAg loss were higher in patients with an ALT flare vs those without, but the rate of HBsAG loss was similar.

Citation:

Brahmania M, Lombardero M, Hansen BE, et al. Association between severe serum alanine aminotransferase flares and hepatitis B e antigen seroconversion and HBV DNA decrease in untreated patients with chronic HBV infection. [Published online ahead of print February 8, 2019]. Clin Gastroenterol Hepatol. doi:10.1016/j.cgh.2019.02.005.